JPMorgan China Growth & Income plc
|Alibaba Group Holding Ltd ADR||11.42 %|
|Tencent Holdings Ltd||10.90 %|
|Ping An Insurance (Group) Co. of China Ltd Class H||5.30 %|
|WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S||3.51 %|
|NetEase Inc ADR||2.72 %|
|Kingdee International Software Group Co Ltd||2.38 %|
|ENN Energy Holdings Ltd||2.27 %|
|Jiangsu Hengrui Medicine Co Ltd||2.26 %|
|Sunny Optical Technology (Group) Co Ltd||2.24 %|
|iQIYI Inc ADR||2.08 %|
|Asia - Emerging||92.78 %|
|Consumer Cyclical||19.57 %|
|Communication Services||16.88 %|
|Financial Services||9.96 %|
|Consumer Defensive||8.61 %|
|Real Estate||6.66 %|
Emerson Yip, managing director, is a country specialist for Greater China equities and a member of the Greater China Team within the Emerging Markets and Asia Pacific (EMAP) Equities Team. Based in Hong Kong, he joined the Firm in 2006 after eight years at Newbridge Capital where he was a director responsible for managing funds dedicated to private equity investment opportunities throughout Asia. During his time at Newbridge, Emerson worked in the Hong Kong, Singapore and San Francisco offices. Emerson began his career with Morgan Stanley in 1994 as a financial analyst in the mergers, acquisitions and restructuring department in New York. Emerson obtained his B.S. magna cum laude in Applied Mathematics and International Studies from Yale University, where he was elected to Phi Beta Kappa.
Shumin Huang, managing director, is a country specialist for Greater China equities and a member of the Greater China Team within the Emerging Markets and Asia Pacific (EMAP) Equities Team. Based in Hong Kong, she joined the Firm in 2006 after eight years at Goldman Sachs, where she was managing director and head of the Asia-Pacific Energy and Chemicals Team. She began her career with UBS Taiwan in 1992 as a research analyst in steel and financials, after which she transferred to Hong Kong as director and head of Asia-Pacific chemicals research. Shumin obtained a B.S. in Business Administration from the National University of Taiwan and an M.B.A. from London Business School.
Howard Wang, managing director, is a country specialist for Greater China equities and head of the Greater China Team within the Emerging Markets and Asia Pacific (EMAP) Equities Team. Based in Hong Kong, he leads the Greater China-dedicated portfolio management teams in Hong Kong and Taipei and serves as the primary advisor for the investment team at J.P. Morgan Asset Management(JPMAM) Shanghai-based joint venture China International Fund Management (CIFM). He joined the Firm in 2005 after eight years at Goldman Sachs, where he was managing director and head of the Taipei office as well as an executive director with Goldman equities principal strategies team in Hong Kong. He began his career with Lazard in 1995 as a financial analyst in mergers & acquisitions in New York. Howard obtained a B.A. summa cum laude in economics from Yale University, where he was elected vice president of Phi Beta Kappa.
Data provided by Morningstar.
The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Moneywise and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.
This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.
You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.